---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Isomorphic Labs

🌎 isomorphiclabs.com

Isomorphic Labs is a new Alphabet company focused on reimagining the drug discovery process using an AI-first approach. Founded in 2021, the company aims to leverage computational advances to unlock deeper scientific insights and accelerate the development of life-changing medicines. With a mission to model and understand fundamental mechanisms of life, Isomorphic Labs is at the forefront of the digital biology era, significantly increasing the pace of scientific research and the efficacy of new medicines.

---

Isomorphic Labs - Latest News and Updates

• Isomorphic Labs is developing generalizable AI models to revolutionize drug development by integrating knowledge across all protein and chemical interactions.
• Isomorphic Labs will participate in RAAIS 2025, focusing on AI policy, image/video generation, and drug discovery.
• Isomorphic Labs is participating in the ICLR 2025 workshops to discuss their use of machine learning in drug discovery and is hiring.
• Isomorphic Labs will participate in the 9th Research and Applied AI Summit in London in June 2025.
• Colin Murdoch, President of Isomorphic Labs, will speak at VivaTech in June about AI-driven drug discovery.

• Adrian Stecuła, Structural Bioinformatics Group Leader at Isomorphic Labs, announced they are hiring Structural Bioinformatics Scientists to work on AI-driven proteome-scale drug discovery.
• Isomorphic Labs is currently hiring for the position of Platform (DevOps) Lead in the United Kingdom.
• Sir Demis Hassabis, associated with Isomorphic Labs, has an ambitious vision for AI in drug discovery.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.